30 Participants Needed

Non-Invasive Brain Stimulation for Traumatic Brain Injury

(SMART Trial)

DD
Overseen ByDavid Darrow, MD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.

What data supports the effectiveness of the treatment COGED, External non-invasive stimulation, for traumatic brain injury?

Research shows that non-invasive brain stimulation, like transcranial direct current stimulation (tDCS), can help improve cognitive function and aid recovery in people with traumatic brain injury by enhancing brain plasticity (the brain's ability to adapt and change).12345

Is non-invasive brain stimulation safe for humans?

Non-invasive brain stimulation, including techniques like transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), has been studied for safety in humans. While more research is needed, current studies suggest it is generally safe, with no major safety concerns reported in trials for traumatic brain injury and other conditions.678910

How is the treatment COGED different from other treatments for traumatic brain injury?

COGED is unique because it uses non-invasive brain stimulation, which means it stimulates the brain from outside the body without surgery. This approach aims to enhance neuroplasticity (the brain's ability to reorganize itself) and improve recovery after a traumatic brain injury, offering a novel way to potentially aid recovery compared to traditional methods.24111213

Research Team

Dr. David Darrow, MD - Minneapolis, MN ...

David Darrow, MD MPH

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for adults over 18 who've had a mild to moderate traumatic brain injury (TBI) and can perform computerized tests. They must understand the consent process and commit to all appointments. It's not for those with severe TBI, scalp wounds, pacemakers/defibrillators, non-English speakers, or visual issues affecting computer use.

Inclusion Criteria

I am over 18, had a mild to moderate brain injury, can do computer tasks, and can follow the study plan.
I am over 18, can do computer tasks, and can attend all appointments.

Exclusion Criteria

I am over 18, speak English, not incarcerated, have no scalp wounds, no TBI, no pacemaker or defibrillator, and can see well enough for computer tasks.
Implanted defibrillator or pacemaker
Visual impairment that hinders ability to complete computerized assessments
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive transcutaneous alternating current stimulation (tACS) or sham stimulation once weekly for six weeks to improve cognitive function and decision-making after traumatic brain injury

6 weeks
6 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • COGED
  • External non-invasive stimulation
Trial OverviewThe study is testing two types of external non-invasive brain stimulation: transcutaneous alternating current stimulation (TACS) and vagal nerve stimulation (tnVNS), aiming to improve cognitive function and decision-making after a TBI.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: StimulationActive Control2 Interventions
Stimulation
Group II: ShamPlacebo Group1 Intervention
No stimulation

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Uniformed Services University of the Health Sciences

Collaborator

Trials
130
Recruited
91,100+

Findings from Research

The review of 10 placebo-controlled studies on non-invasive brain stimulation (NIBS) for cognitive performance in traumatic brain injury (TBI) patients found insufficient high-quality evidence to support its effectiveness, particularly for cognitive functions other than attention.
While NIBS showed some potential benefits for depression in TBI patients, it did not consistently improve other cognitive deficits like executive function or memory, highlighting the need for further research due to the high risk of bias in the studies reviewed.
The Effectiveness of Non-Invasive Brain Stimulation Alone or Combined with Cognitive Training on the Cognitive Performance of Patients With Traumatic Brain Injury: Α Systematic Review.Nousia, A., Martzoukou, M., Liampas, I., et al.[2022]
Noninvasive brain stimulation (NBS) techniques, such as transcranial magnetic stimulation and transcranial direct current stimulation, show potential for both assessing and treating traumatic brain injury (TBI) by modulating brain activity and promoting recovery.
These techniques may help suppress harmful brain activity immediately after injury and enhance recovery during rehabilitation, but further safety research and clinical trials are needed to confirm their effectiveness and establish best practices for use in TBI patients.
Noninvasive brain stimulation in traumatic brain injury.Demirtas-Tatlidede, A., Vahabzadeh-Hagh, AM., Bernabeu, M., et al.[2022]
Transcranial direct current stimulation (tDCS) is a safe and non-invasive treatment that shows promise in improving cognitive recovery in patients with traumatic brain injury (TBI), as evidenced by multiple studies reporting enhanced coma recovery and cognitive performance.
While tDCS can be effective on its own, combining it with other therapies like cognitive rehabilitation and physical therapy may lead to even better outcomes, and neurophysiological measures like EEG and TMS can serve as useful biomarkers for tracking progress.
Transcranial direct current stimulation (tDCS) effects on traumatic brain injury (TBI) recovery: A systematic review.Zaninotto, AL., El-Hagrassy, MM., Green, JR., et al.[2022]

References

The Effectiveness of Non-Invasive Brain Stimulation Alone or Combined with Cognitive Training on the Cognitive Performance of Patients With Traumatic Brain Injury: Α Systematic Review. [2022]
Noninvasive brain stimulation in traumatic brain injury. [2022]
Transcranial direct current stimulation (tDCS) effects on traumatic brain injury (TBI) recovery: A systematic review. [2022]
Noninvasive brain stimulation to modulate neuroplasticity in traumatic brain injury. [2022]
Efficacy of Non-Invasive Brain Stimulation for Treating Depression in Patients with Traumatic Brain Injury: A Meta-Analysis and Meta-Regression of Randomized Controlled Trials. [2023]
Cortical Brain Stimulation with Endovascular Electrodes. [2020]
A Swine Model of Traumatic Brain Injury: Effects of Neuronally Generated Electromagnetic Fields and Electromagnetic Field Stimulation on Traumatic Brain Injury-Related Changes. [2023]
The Effect of Non-Invasive Brain Stimulation (NIBS) on Executive Functioning, Attention and Memory in Rehabilitation Patients with Traumatic Brain Injury: A Systematic Review. [2021]
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial. [2022]
10.Georgia (Republic)pubmed.ncbi.nlm.nih.gov
NEUROPLASTICITY AND BRAIN STIMULATION: DEVELOPING INTERVENTIONS TO PROMOTE RECOVERY FROM STROKE AND TRAUMATIC BRAIN INJURY. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Noninvasive cortical stimulation in neurorehabilitation: a review. [2016]
12.United Statespubmed.ncbi.nlm.nih.gov
Consensus: Motor cortex plasticity protocols. [2016]
Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence. [2022]